| 0 |
CD19-directed Chimeric Antigen Receptor [EPC] |
4 |
0.0004 |
| 1 |
CD38-directed Cytolytic Antibody [EPC] |
2 |
0.0003 |
| 2 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
1 |
0.0002 |
| 3 |
Topoisomerase Inhibitor [EPC] |
16 |
0.0002 |
| 4 |
Alkylating Drug [EPC] |
24 |
0.0001 |
| 5 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
1 |
0.0001 |
| 6 |
Asparagine-specific Enzyme [EPC] |
1 |
0.0001 |
| 7 |
Thrombopoietin Receptor Agonist [EPC] |
1 |
0.0001 |
| 8 |
Purine Antimetabolite [EPC] |
5 |
0.0001 |
| 9 |
CD20-directed Cytolytic Antibody [EPC] |
11 |
0.0000 |
| 10 |
BCL-2 Inhibitor [EPC] |
2 |
0.0000 |
| 11 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
0.0000 |
| 12 |
Platinum-based Drug [EPC] |
8 |
0.0000 |
| 13 |
Folate Analog Metabolic Inhibitor [EPC] |
12 |
0.0000 |
| 14 |
Nucleoside Metabolic Inhibitor [EPC] |
6 |
0.0000 |
| 15 |
Muscle Relaxant [EPC] |
1 |
0.0000 |
| 16 |
CTLA-4-directed Blocking Antibody [EPC] |
1 |
0.0000 |
| 17 |
Kinase Inhibitor [EPC] |
11 |
0.0000 |
| 18 |
Corticosteroid [EPC] |
25 |
0.0000 |
| 19 |
Interleukin-12 Antagonist [EPC] |
2 |
0.0000 |
| 20 |
Interleukin-23 Antagonist [EPC] |
2 |
0.0000 |
| 21 |
Proteasome Inhibitor [EPC] |
2 |
0.0000 |
| 22 |
Thalidomide Analog [EPC] |
6 |
0.0000 |
| 23 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 24 |
Leukocyte Growth Factor [EPC] |
1 |
0.0000 |
| 25 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 26 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 29 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 31 |
Vitamin D [EPC] |
1 |
0.0000 |
| 32 |
Vitamin B12 [EPC] |
1 |
0.0000 |
| 33 |
Vitamin C [EPC] |
1 |
0.0000 |
| 34 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 35 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 36 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |